Navigation Links
Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010
Date:2/1/2011

NATICK, Mass., Feb. 1, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for the fourth quarter and full year ended December 31, 2010, as well as net sales and earnings per share (EPS) guidance for the full year and first quarter 2011.

Fourth quarter highlights:

  • Reported sales of $2.002 billion with GAAP earnings of $0.15 per diluted share and adjusted earnings per diluted share of $0.20.

  • Increased year-over-year International ICD reported sales 6 percent (including 3 points of unfavorable foreign exchange impact), supported by the introduction of several new technologies.

  • Received CE Mark approval for INCEPTA™, ENERGEN™ and PUNCTUA™, the Company's next-generation cardiac resynchronization therapy defibrillators (CRT-Ds) and implantable cardioverter defibrillators (ICDs).

  • Maintained leadership position in the global drug-eluting stent (DES) market with 35 percent share worldwide and U.S. share of 46 percent.  Rapidly increased growth in PROMUS® Element™ sales throughout 2010 with sales of $227 million, exiting the year with nearly a quarter of the European DES market.

  • Increased worldwide Neuromodulation sales 8 percent and Endoscopy sales 6 percent.

  • Executed on several Priority Growth Initiatives through the recently announced acquisitions of Asthmatx, Sadra Medical, Atritech and Intelect Medical.

  • Divested Neurovascular business in January 2011 for $1.5 billion, with expected after-tax proceeds of $1.2 billion.

  • Prepaid all $600 million of senior notes due in June 2011 and paid at maturity $250 million of senior notes in January 2011.

  • "We've made significant progress in our strategy to realign our portfolio through the execution of our Priority Growth Initiatives, with four targete
    '/>"/>

    SOURCE Boston Scientific Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

    Related medicine technology :

    1. Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System
    2. Boston Scientific Responds to DOJ Civil Lawsuit
    3. Boston Scientific Announces First Use of Blazer® Open-Irrigated Catheter in U.S.
    4. Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent
    5. Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent
    6. Boston Scientific Announces Agreement With Fukuda Denshi for Distribution of Cardiac Rhythm Management Products in Japan
    7. Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2010 Financial Results
    8. Boston Scientific to Acquire Atritech
    9. Boston Scientific Completes Enrollment in Clinical Trial Evaluating Next-Generation Nitinol Stent to Treat Iliac Artery Disease
    10. Statement of Kenneth Stein, M.D., Chief Medical Officer, Cardiac Rhythm Management, Boston Scientific on JAMA Article
    11. Boston Scientific Completes Acquisition of Sadra Medical
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)... Research and Markets has announced ... Report, 2014-2017" report to their offering. ... of reimbursement for medical expenses, the Chinese orthopedic instrument ... presenting a CAGR of 19.2% during 2009-2013. Trauma products, ... of orthopedic instruments in China , ...
    (Date:8/29/2014)... 29, 2014 Does your doctor know what you,re ... have recommended marijuana to the over 112,000 currently registered patients ... majority of the other roughly 20,300+ active physicians listed with ... about it – even though a poll in February 2014 ... they have tried it. "With marijuana legalization ...
    (Date:8/29/2014)... , August 29, 2014 ... by Product & Services (Equipment, Reagent, Primer, Probe, ... (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) ... the global Oligonucleotide Synthesis Market is expected to ... in 2014, growing at a CAGR of 9.8% ...
    Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
    ... Dec. 22, 2011 Over 130 organizations, community leaders, ... neighborhoods and inner-cities across the country today urged Express ... Walgreens. This agreement is necessary to protect access to pharmacy ... "We strongly urge Express Scripts to put the people ...
    ... Biopharmaceuticals Corp. ("Provenance") announced today the closing of ... LLC for the continued development of anti-cancer therapeutic, ... of molecules called immunocytokines that are being developed ... Immunocytokines, combine the immune stimulating features of cytokines ...
    Cached Medicine Technology:Over 130 Community Leaders and Organizations Across the Nation Urge Express Scripts To Reach Agreement With Walgreens 2Provenance Biopharmaceuticals Corp. Announces $8M Financing Arrangement 2
    (Date:8/29/2014)... 2014 Indosoft, Inc., a leading provider ... of monthly per-port licensing of its Q-Suite 5.7 software. ... solutions, Indosoft has been successfully deploying and supporting its ... contact centers around the world for more than a ... give clients another option which complements the widespread deployment ...
    (Date:8/29/2014)... 29, 2014 Dr. Parsa Mohebi, founder ... rename his practice to Parsa Mohebi Hair Restoration. Since ... the needs of hair loss patients throughout Southern California. ... centers in Los Angeles, Beverly Hills, and Orange County. ... surgical treatments, many of which Dr. Mohebi perfected through ...
    (Date:8/29/2014)... 29, 2014 Dr. Mohebi’s lecture on ... talked about introducing these cutting edge techniques at their ... the FUE Research Committee has allowed him the ability ... is possible with modern technology. Dr. Mohebi stated, “We ... FUE devices that facilitate extraction and implantation of hair ...
    (Date:8/29/2014)... UWDress.com, one of the most famous ... collection of 2014 floor length bridesmaid dresses . ... wonderful items. According to the company’s marketing specialist, all ... discounted rate (up to 60 percent off) before September ... a special neckline: strapless, one-shoulder, bateau and more. The ...
    (Date:8/29/2014)... (PRWEB) August 29, 2014 As reported by ... Addicts' Recovery , an Ohio municipal court drug has come ... addiction. Fred Moses, who serves as the presiding judge in ... law makers to offer addicts a medicated treatment option that ... utilizes the drug known as Vivitrol, which blocks receptors in ...
    Breaking Medicine News(10 mins):Health News:Indosoft Offers Monthly Usage Licensing Terms 2Health News:US Hair Restoration Changes Name to Parsa Mohebi Hair Restoration to Better Reflect Founder 2Health News:Parsa Mohebi M.D., Beverly Hills Hair Restoration Surgeon Gives Inspiring Lecture on Groundbreaking Techniques in Follicular Unit Extraction 2Health News:2014 Floor Length Bridesmaid Dresses for Sale at UWDress.com 2Health News:Ohio Judge Pushes for Addiction Recovery Tool 2Health News:Ohio Judge Pushes for Addiction Recovery Tool 3
    ... 2007 The Procter &,Gamble Company (NYSE: PG ... Earth,Inc. of Irving, Texas, for the infringement of various ... filed today in the United States Federal District Court ... company,s Olay,Regenerist brand. P&G claims infringement on three patents ...
    ... report woman is eating, drinking and smiling 18 months later ... woman who underwent a partial face transplant after being mauled ... months after the landmark surgery. , The surgery was the ... break new ground, both medically and ethically. In the Dec. ...
    ... for sleep disorders , WEDNESDAY, Dec. 12 ... genetic mechanism regulating the body,s internal clock has been ... added that the switch offers a target for the ... related problems. , The study found that a single ...
    ... independent panel convened this week by the NIH ... fecal or urinary incontinencethe inability to control bowel ... providers without being prompted. The secrecy and distress ... for millions, and hamper scientific understanding and development ...
    ... at The Warren Alpert Medical School of Brown University have ... tests for HIV, a relatively new tool in the fight ... of rapid HIV tests, which can be administered simply with ... Results are available in minutes. Brown researchers created the video ...
    ... "Reggie" Washington, a,national force in fighting cardiovascular ... the first Chief Medical Officer for HCA-HealthONE ... starts January 1,2008, overseeing clinical operations for ... the campus of Presbyterian/St. Luke,s Medical Center ...
    Cached Medicine News:Health News:Procter & Gamble Files Infringement Lawsuit 2Health News:Partial Face Transplant Patient Doing Well 2Health News:Partial Face Transplant Patient Doing Well 3Health News:NIH panel seeks to dispel stigma associated with fecal and urinary incontinence 2Health News:NIH panel seeks to dispel stigma associated with fecal and urinary incontinence 3Health News:Brown researchers create first-ever HIV rapid test video 2Health News:Brown researchers create first-ever HIV rapid test video 3Health News:HealthONE(R) Appoints Nationally Renowned Pediatric Cardiologist & Childhood Obesity Expert as First Chief Medical Officer for the Rocky Mountain Hospital for Children(SM) 2Health News:HealthONE(R) Appoints Nationally Renowned Pediatric Cardiologist & Childhood Obesity Expert as First Chief Medical Officer for the Rocky Mountain Hospital for Children(SM) 3Health News:HealthONE(R) Appoints Nationally Renowned Pediatric Cardiologist & Childhood Obesity Expert as First Chief Medical Officer for the Rocky Mountain Hospital for Children(SM) 4
    ... (OSS) from Biomet Inc. offers the ... specifically for orthopaedic surgeons and oncologists ... their patients: significant bone loss, ligamentous ... arthroplasties, and multiple hip revision arthroplasties. ...
    DePuy's Shoe Boots are sealed thermoplastic boots that help provide splash protection from microorganisms, particulate matter and body fluids....
    ... The Nidek NM-200D's compact, lightweight body ... more options to treat more patients, more ... ease of operation and functionality for image ... image data to the compact flash card. ...
    ... Laboratory is a comprehensive, ... manages specimen data from ... tracking to final cumulative ... is a multi-module system ...
    Medicine Products: